Literature DB >> 31302425

Pharmacodynamic effects of Dan-hong injection in rats with blood stasis syndrome.

Cong Bi1, Pan-Lin Li1, Yan Liao1, Hong-Yu Rao1, Pei-Bo Li1, Jing Yi1, Wei-Yue Wang1, Wei-Wei Su2.   

Abstract

Dan-hong injection (DHI) is extracted from Salvia miltiorrhiza (SM) and Carthamus tinctorius (CT) and is widely used for the treatment of cardiovascular diseases. Our previous results showed DHI could improve hemorheology in rats. Since complex cellular interactions such as inflammation and oxidative stress are believed to be implicated in the pathogenesis of cardiovascular events, investigation of such pathological factors will contribute substantially to the understanding of the features and mechanisms of DHI. Therefore, in this study we used a rat model of blood stasis to explore the overall effects of DHI by detecting twenty three indexes, which were related to inflammation, immune response, vascular endothelial function, myocardial energy metabolism, oxidative stress, platelet aggregation, liver and renal function. Meanwhile, the interaction between SM and CT was discussed by comparing the effects of each single herb. DHI could significantly decrease the serum contents of IL-1β, TNF-α, IL-6, IL-8, IgM, IgG, IgA, MPO, hs-CRP, MDA, LDH, CK-MB, PAF, ALP and Cr, while elevate NO, SOD, TP and UA levels, indicating that DHI could inhibit inflammation and platelet aggregation, thereby relieving immune response and peroxidation, protecting vascular endothelial and organ function, and then prevent and treat cardiovascular diseases. In terms of compatibility, SM and CT showed complementary effects on markers of inflammatory and oxidative status, vascular endothelial damage and myocardial energy metabolism. On the other hand, they counteracted each other and SM reduced the side effects of creatinine caused by CT. This study contributes to comprehensively understand the pharmacodynamics effects and mechanism of DHI.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; Chinese herbal formula; Endothelial function; Immune response; Inflammation; Liver function; Myocardial energy metabolism; Oxidative stress; Platelet-activating factor; Prescription compatibility connotation; Renal function

Mesh:

Substances:

Year:  2019        PMID: 31302425     DOI: 10.1016/j.biopha.2019.109187

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation.

Authors:  Siyu Guo; Yingying Tan; Zhihong Huang; Yikui Li; Weiyu Liu; Xiaotian Fan; Jingyuan Zhang; Antony Stalin; Changgeng Fu; Zhishan Wu; Penglong Wang; Wei Zhou; Xinkui Liu; Chao Wu; Shanshan Jia; Jinyan Zhang; Xiaoxia Duan; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

2.  Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.

Authors:  Wei-Jian Zhang; Wei-Wei Su; Qing-Wei Lin; Yan He; Zeng-Hao Yan; Yong-Gang Wang; Pei-Bo Li; Hao Wu; Hong Liu; Hong-Liang Yao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.